Soleno Therapeutics, Inc.
US ˙ NasdaqCM ˙ US8342033094

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Frank Kung. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Frank Kung har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AMRS / Amyris Inc Director 0
US:SGNT / Sagent Pharmaceuticals, Inc. Director 921
US:SLNO / Soleno Therapeutics, Inc. 10% Owner 945.200
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Frank Kung. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb SLNO / Soleno Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SLNO / Soleno Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 1.936.843 193.684 731 0.9700
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 22.729 2.273
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 28.028 2.803
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 6.689 669
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 122 12
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 348.800 34.880
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 4.093 409
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 585.437 58.544
2014-11-18 CAPN Vivo Ventures Fund V, L.P. 6.870 687

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SLNO / Soleno Therapeutics, Inc. Insider Trades
Insidersalg SLNO / Soleno Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SLNO / Soleno Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SLNO / Soleno Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Frank Kung som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-05-07 2024-05-07 4 AMRS AMYRIS, INC.
Common Stock
J - Other -16.207 0 -100,00
2024-05-07 2024-05-07 4 AMRS AMYRIS, INC.
Common Stock
J - Other -938.416 0 -100,00
2024-05-07 2024-05-07 4 AMRS AMYRIS, INC.
Common Stock
J - Other -6.796.205 0 -100,00
2022-09-23 2022-09-21 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -36.488 0 -100,00 3,50 -127.708
2022-09-23 2022-09-21 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -163.512 0 -100,00 3,50 -572.292
2022-09-23 2022-09-20 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -72.972 36.488 -66,67 3,60 -262.699 131.357
2022-09-23 2022-09-20 4/A AMRS AMYRIS, INC.
Common Stock
S - Sale X -327.028 163.512 -66,67 3,60 -1.177.301 588.643
2022-09-22 2022-09-21 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -36.488 0 -100,00 3,50 -127.708
2022-09-22 2022-09-21 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -163.512 0 -100,00 3,50 -572.292
2022-09-22 2022-09-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -72.972 36.488 -66,67 3,60 -262.699 131.357
2022-09-22 2022-09-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -327.028 163.512 -66,67 3,60 -1.177.301 588.643
2022-09-19 2022-09-19 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -197.148 109.460 -64,30 3,80 -749.162 415.948
2022-09-19 2022-09-19 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -883.528 490.540 -64,30 3,80 -3.357.406 1.864.052
2022-09-19 2022-09-16 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -151.983 306.608 -33,14 3,60 -547.139 1.103.789
2022-09-19 2022-09-16 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -681.117 1.374.068 -33,14 3,60 -2.452.021 4.946.645
2022-09-19 2022-09-15 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -252.667 458.591 -35,52 4,20 -1.061.201 1.926.082
2022-09-19 2022-09-15 4 AMRS AMYRIS, INC.
Common Stock
S - Sale X -1.132.333 2.055.185 -35,52 4,20 -4.755.799 8.631.777
2022-08-29 2022-08-23 4/A AMRS AMYRIS, INC.
Common Stock
J - Other 7.409 16.207 84,21
2022-08-29 2022-08-23 4/A AMRS AMYRIS, INC.
Common Stock
J - Other -7.409 80.000 -8,48
2022-08-29 2022-08-22 4/A AMRS AMYRIS, INC.
Common Stock
A - Award 80.000 87.409 1.079,77
2022-08-24 2022-08-22 4 AMRS AMYRIS, INC.
Common Stock
A - Award 80.000 80.000
2021-08-26 2021-08-23 4/A AMRS AMYRIS, INC.
Common Stock
A - Award 7.409 7.409
2021-08-25 2021-08-23 4 AMRS AMYRIS, INC.
Common Stock
A - Award 7.409 7.409
2021-08-09 2021-08-05 4 AMRS AMYRIS, INC.
Common Stock
J - Other 2.266 8.798 34,69
2021-08-09 2021-08-05 4 AMRS AMYRIS, INC.
Common Stock
J - Other -2.266 0 -100,00
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -147.111 0 -100,00 4,76 -700.248
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -1.065.676 0 -100,00 4,76 -5.072.618
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 147.111 938.416 18,59 4,76 700.248 4.466.860
2021-04-15 2021-04-14 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 1.065.676 6.796.205 18,60 4,76 5.072.618 32.349.936
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -1.005 0 -100,00
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -7.275 0 -100,00
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -286.032 711.258 -28,68 14,96 -4.279.754 10.642.198
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -1.281.858 3.187.518 -28,68 14,96 -19.179.800 47.693.238
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -377.384 791.305 -32,29 14,96 -5.646.608 11.839.901
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -2.733.089 5.730.529 -32,29 14,96 -40.893.844 85.743.040
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 235.829 1.168.689 25,28 4,26 1.004.632 4.978.615
2021-04-15 2021-04-13 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 1.707.830 8.463.618 25,28 4,26 7.275.356 36.055.013
2020-11-04 2020-11-02 4 AMRS AMYRIS, INC.
Common Stock
J - Other 666 6.532 11,35
2020-11-04 2020-11-02 4 AMRS AMYRIS, INC.
Common Stock
J - Other -666 2.266 -22,71
2020-10-27 2020-10-23 4 AMRS AMYRIS, INC.
Common Stock
J - Other 2.266 5.866 62,94
2020-10-27 2020-10-23 4 AMRS AMYRIS, INC.
Common Stock
J - Other -2.266 2.932 -43,59
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 3.466 3.466
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2.266 5.198 77,29
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 3.466 3.466
2020-08-07 2020-08-05 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2.266 5.198 77,29
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 195 195 1.000,00 195.082 195.082
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 1.336 1.336 1.000,00 1.336.216 1.336.216
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 1.413 1.413 1.000,00 1.412.736 1.412.736
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Series E Convertible Preferred Stock
P - Purchase 5.988 5.988 1.000,00 5.988.286 5.988.286
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 551.884 551.884 3,00 1.655.652 1.655.652
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 80.573 867.832 10,23 3,00 241.719 2.603.496
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 2.473.280 2.473.280 3,00 7.419.840 7.419.840
2020-06-09 2020-06-05 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 583.488 6.284.876 10,23 3,00 1.750.464 18.854.628
2019-11-05 2019-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other 667 3.600 22,74
2019-11-05 2019-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other -667 2.932 -18,53
2019-10-25 2019-10-23 4 AMRS AMYRIS, INC.
Stock Option (Right to Buy)
A - Award 3.466 3.466
2019-10-25 2019-10-23 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2.266 3.599 169,99
2019-08-05 2019-08-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other 2.266 2.933 339,73
2019-08-05 2019-08-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other -2.266 1.333 -62,96
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
P - Purchase 147.111 147.111 0,12 18.389 18.389
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
P - Purchase 1.065.676 1.065.676 0,12 133.210 133.210
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 110.811 787.259 16,38 4,76 527.460 3.747.353
2019-05-01 2019-04-29 4 AMRS AMYRIS, INC.
Common Stock
P - Purchase 802.718 5.701.388 16,39 4,76 3.820.938 27.138.607
2018-11-02 2018-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other 667 667
2018-11-02 2018-11-01 4 AMRS AMYRIS, INC.
Common Stock
J - Other -667 3.599 -15,64
2018-08-24 2018-08-20 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 256.251 256.251
2018-08-24 2018-08-20 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 1.855.706 1.855.706
2018-08-24 2018-08-17 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 619.749 619.749
2018-08-24 2018-08-17 4/A AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 4.488.072 4.488.072
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 256.251 256.251
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 1.855.706 1.855.706
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -197.877 0 -100,00
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -1.432.977 0 -100,00
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 197.877 676.448 41,35 4,40 870.659 2.976.371
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 1.432.977 4.898.670 41,35 4,40 6.305.099 21.554.148
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -139.306 478.571 -22,55 6,22 -866.316 2.976.137
2018-08-21 2018-08-20 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -1.008.816 3.465.693 -22,55 6,22 -6.273.625 21.552.452
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 619.749 619.749
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
A - Award 4.488.072 4.488.072
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
D - Sale to Issuer 0 0
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
D - Sale to Issuer 0 0
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -478.571 197.877 -70,75
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Warrant (Right to Buy)
M - Exercise -3.465.693 1.432.977 -70,75
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Series D Convertible Preferred Stock
M - Exercise -568 1.005 -36,10
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Series D Convertible Preferred Stock
M - Exercise -4.111 7.275 -36,10
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 478.571 617.877 343,54 4,40 2.105.712 2.718.659
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 3.465.693 4.474.509 343,54 4,40 15.249.049 19.687.840
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -336.914 139.306 -70,75 6,22 -2.095.201 866.316
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
S - Sale -2.439.848 1.008.816 -70,75 6,22 -15.172.927 6.273.625
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 133.246 476.220 38,85 4,26 567.628 2.028.697
2018-08-21 2018-08-17 4 AMRS AMYRIS, INC.
Common Stock
M - Exercise 964.927 3.448.664 38,85 4,26 4.110.589 14.691.309
2018-08-03 2018-08-01 4 AMRS AMYRIS, INC.
Stock Option (Right to Buy)
A - Award 3.466 3.466
2018-08-03 2018-08-01 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2.266 4.266 113,30
2017-11-08 2017-11-06 4 AMRS AMYRIS, INC.
Stock Option (Right to Buy)
A - Award 3.000 3.000
2017-11-08 2017-11-06 4 AMRS AMYRIS, INC.
Common Stock
A - Award 2.000 2.000
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
5.310.448
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
3.169.685
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
5.310.448
2017-11-08 3 AMRS AMYRIS, INC.
Common Stock
3.169.685
2015-04-13 2015-04-09 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 921 921
2015-02-27 2015-02-25 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 1.841 1.841
2015-02-24 2015-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -567 567 -50,00
2015-02-24 2015-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 567 36.909 1,56
2015-02-24 2015-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -760 1.520 -33,33
2015-02-24 2015-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 760 36.342 2,14
2015-02-20 2015-02-18 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -930 2.790 -25,00
2015-02-20 2015-02-18 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 930 35.582 2,68
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 6.870 945.200 0,73
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 6.870 945.200 0,73
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 585.437 938.330 165,90
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 585.437 938.330 165,90
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 4.093 352.893 1,17
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 4.093 352.893 1,17
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Warrant to Purchase Common Stock
P - Purchase 348.800 348.800
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Warrant to Purchase Common Stock
P - Purchase 348.800 348.800
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 17 331.111 0,01
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 1.002 331.094 0,30
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 4.205 330.092 1,29
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 3.778 325.887 1,17
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Warrant to Purchase Common Stock
J - Other 322.109 322.109
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series A Preferred Stock
C - Conversion -31.250 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Preferred Stock
C - Conversion -1.755 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Preferred Stock
C - Conversion -95.112 1.755 -98,19
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series B Preferred Stock
C - Conversion -19.766 96.867 -16,95
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -1.102 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -59.638 1.102 -98,19
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -178.408 64.740 -73,37
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -240 239.148 -0,10
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Series C Preferred Stock
C - Conversion -137.277 239.388 -36,45
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2014 Convertible Promissory Notes
S - Sale -18.401 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2014 Convertible Promissory Notes
S - Sale -1.567.879 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -596 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -32.569 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -136.441 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -110.642 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
2010/2012 Convertible Promissory Notes
S - Sale -9.427.595 0 -100,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 6.870 3.497.288 0,20
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 585.437 3.490.418 20,15
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 4.093 2.904.981 0,14
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 348.800 2.900.888 13,67
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 122 2.552.088 0,00
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 6.689 2.551.966 0,26
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 28.028 2.545.277 1,11
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 22.729 2.517.249 0,91
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
P - Purchase 1.936.843 2.494.520 347,31
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 31.250 557.677 5,94
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 1.755 526.427 0,33
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 95.112 524.672 22,14
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 19.766 429.560 4,82
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 1.102 409.794 0,27
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 59.638 408.692 17,09
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 178.408 349.054 104,55
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 1.611 170.646 0,95
2014-11-20 2014-11-18 4 CAPN Capnia, Inc.
Common Stock
C - Conversion 137.277 169.035 432,26
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
52.390
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.486
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
37.059
2014-11-12 3 CAPN Capnia, Inc.
Common Stock
31.855
2014-02-24 2014-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -567 1.134 -33,33
2014-02-24 2014-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 567 34.652 1,66
2014-02-24 2014-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -759 2.280 -24,98
2014-02-24 2014-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 759 34.085 2,28
2014-02-19 2014-02-18 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 3.720 3.720
2013-09-17 2013-09-16 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
S - Sale -622.700 4.180.791 -12,96 21,25 -13.232.375 88.841.809
2013-09-17 2013-09-16 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
S - Sale -539.017 3.618.946 -12,96 21,25 -11.454.111 76.902.602
2013-02-25 2013-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
M - Exercise -567 1.701 -25,00
2013-02-25 2013-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 567 33.326 1,73
2013-02-25 2013-02-21 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 3.039 3.039
2012-06-04 2012-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Stock Option to Buy/Restricted Stock
M - Exercise -3.190 0 -100,00
2012-06-04 2012-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.190 32.759 10,79 4,23 13.494 138.571
2012-04-19 2011-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Stock Option to Buy/Restricted Stock
M - Exercise -3.190 3.189 -50,01
2012-04-19 2011-06-01 4 SGNT Sagent Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.190 29.569 12,09 4,23 13.494 125.077
2012-02-24 2012-02-22 4 SGNT Sagent Pharmaceuticals, Inc.
Restricted Stock Units
A - Award 2.268 2.268
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)